Since platelets contribute to the cytokine storm observed in severe COVID-19, anti-inflammatory agents like corticosteroids (e.g. dexamethasone) and interleukin-6 (IL-6) inhibitors (e.g. tocilizumab) have been used to manage the excessive inflammation. Here, IL6 is linked to COVID-19.